CRISPRmod dCas9-VPR or dCas9- SALL1-SDS3 mRNA and synthetic guide RNA transfection protocol
- Clarence Mills 1,2
- 1 - Horizon Team
- 2 - Horizon/Perkin Elmer
Aug 10, 2021
The following is a protocol for transfecting CRISPRmod dCas9-VPR or dCas9-SALL1-SDS3 mRNA with synthetic guide RNA into cultured mammalian cells using DharmaFECT™ Duo transfection reagent (Cat #T-2010-xx). The protocol is written for transfection into 96-well tissue culture plates.
The CRISPR activation (CRISPRa) system is a variation of the canonical CRISPR-Cas9 used for creation of double-strand breaks in genomic DNA. It utilizes a nuclease-deactivated S. pyogenes Cas9 (dCas9), often called "dead Cas9", that is fused to one or more transcriptional activators. When paired with a well-designed guide RNA that targets a gene near a promoter region, the gene's native transcription start site is activated
dCas9-VPR mRNA expresses a human codon-optimized version of the nuclease-deactivated S. pyogenes Cas9 gene, the three transcriptional activators (VP64, p65 and Rta), and two nuclear localization signals (NLS). The dCas9-VPR mRNA is available in a form that co-expresses either EGFP or puromycin for transfection optimization or enrichment using fluorescence-activated cell sorting (FACS) or antibiotic selection.
Reagents and Equipment
DharmaFECT™ Duo transfection reagent (Cat #T-2010-xx)
Time Taken1 hour
PrimerFluorination Increases Bioavailability and Stability of Natural Therapeutics
MixerSpatial Biology Tools and Techniques
PrimerTechniques to Detect Unusual Nucleic Acid Structures
PrimerCyclic Microchip Assay Enhances Throughput of Protein Detection in Single Cells
ProtocolHigh-Throughput In Vitro, Ex Vivo, and In Vivo Screen of Adeno-Associated Virus Vectors Based on Physical and Functional Transduction